• S Francque
  • N Lanthier
  • L Verbeke
  • C Van Steenkiste
  • L Vonghia
  • W J Kwanten
  • E Trépo
  • D Cassiman
  • F Smets
  • M Komuta
  • A Driessen
  • E Dirinck
  • E Danse
  • B Op de Beeck
  • E van Craenenbroeck
  • G Hubens
  • C Moreno

Non-Alcoholic Fatty Liver Disease (NAFLD) is highly prevalent and associated with considerable liver-related and non-liverrelated morbidity and mortality. There is, however, a lot of uncertainty on how to handle NAFLD in clinical practice. The current guidance document, compiled under the aegis of the Belgian Association for the Study of the Liver by a panel of experts in NAFLD, from a broad range of different specialties, covers many questions encountered in daily clinical practice regarding diagnosis, screening, therapy and follow-up in adult and paediatric patients. Guidance statements in this document are based on the available evidence whenever possible. In case of absence of evidence or inconsistency of the data, guidance statements were formulated based on consensus of the expert panel. This guidance document is intended as a help for clinicians (general practitioners and all involved specialties) to implement the most recent evidence and insights in the field of NAFLD within a Belgian perspective.

Original languageEnglish
Pages (from-to)55-81
Number of pages27
JournalActa Gastro-Enterologica Belgica
Volume81
Issue number1
Publication statusPublished - 22 Mar 2018

    Research areas

  • Clinical practice, Guidance, NAFLD, Screening algorithm, Treatment algorithm

ID: 36942955